Transferrin receptor (CD71) expression on circulating mononuclear cells during pregnancy

Am J Obstet Gynecol. 1994 Jan;170(1 Pt 1):202-6. doi: 10.1016/s0002-9378(94)70408-2.

Abstract

Objective: We studied transferrin receptor (CD71) expression in peripheral blood mononuclear cells from healthy pregnant women, to determine if a relationship existed between gestational age and circulating CD71+ mononuclear cells.

Study design: Cell suspensions were prepared from venous blood from 139 pregnant women (7 to 26 weeks of gestation), incubated with monoclonal anti-CD71 antibody, and analyzed by flow cytometry.

Results: When only the first sample from each woman was analyzed, extensive biologic variation between women was shown. An apparent biphasic increase in the percentage of CD71+ cells with advancing gestation was suggested. A subgroup of 13 women studied on multiple occasions demonstrated linear increases in CD71+ cells as pregnancy progressed.

Conclusions: Pregnant women, when compared with each other, may have differences in the baseline number of circulating CD71+ cells. The increases seen in individuals studied repeatedly are likely to reflect maternal hematopoiesis and current fetomaternal transfusion.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amniocentesis / adverse effects
  • Cross-Sectional Studies
  • Female
  • Flow Cytometry
  • Follow-Up Studies
  • Humans
  • Leukocytes, Mononuclear / metabolism*
  • Pregnancy / blood*
  • Pregnancy Trimester, First
  • Pregnancy Trimester, Second
  • Receptors, Transferrin / biosynthesis*
  • Regression Analysis

Substances

  • Receptors, Transferrin